Therapeutic Action of the Mitochondria-Targeted Antioxidant SkQ1 on Retinopathy in OXYS Rats Linked with Improvement of VEGF and PEDF Gene Expression
2011

Effects of SkQ1 on Retinopathy in OXYS Rats

Sample size: 60 publication 10 minutes Evidence: moderate

Author Information

Author(s): Markovets Anton M., Fursova Anzhella Z., Kolosova Natalia G.

Primary Institution: Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences (SB RAS), Novosibirsk, Russia

Hypothesis

Does the mitochondria-targeted antioxidant SkQ1 affect the expression of VEGF and PEDF genes in OXYS rats with retinopathy?

Conclusion

SkQ1 supplementation prevents the development of retinopathy in OXYS rats and normalizes the expression of VEGF and PEDF genes.

Supporting Evidence

  • SkQ1 supplementation prevented the development of retinopathy in OXYS rats.
  • VEGF mRNA and protein levels were normalized in OXYS rats treated with SkQ1.
  • SkQ1 did not cause negative effects on the retina of control Wistar rats.

Takeaway

SkQ1 is a special antioxidant that helps prevent eye problems in aging rats, making their eyes healthier.

Methodology

The study involved OXYS and Wistar rats, with SkQ1 administered in food and as eye drops, followed by gene expression analysis using real-time PCR and ELISA.

Potential Biases

Potential bias in the selection of animal models and the interpretation of results.

Limitations

The study primarily focuses on animal models, which may not fully replicate human conditions.

Participant Demographics

Male senescence-accelerated OXYS and age-matched male Wistar rats.

Statistical Information

P-Value

p<0.0005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0021682

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication